Metabolism and cytotoxic effects of 2-chloroadenine, the major catabolite of 2-chloro-2′-deoxyadenosine
- 23 March 2000
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 59 (10) , 1237-1243
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- The Clinical Pharmacokinetics of CladribineClinical Pharmacokinetics, 1997
- 2-Chloro-2′-deoxyadenosine: clinical applications in hematologyBlood Reviews, 1996
- On the Phosphorylation of 2-chlorodeoxy-adenosine (CdA) and Its Correlation with Clinical Response in Leukemia TreatmentLeukemia & Lymphoma, 1996
- A Novel Effect of the New Antileukemic Drug, 2-Chloro-2′-deoxyadenosine, in Human LymphocytesBiochemical and Biophysical Research Communications, 1994
- Phosphorylation of 2-chlorodeoxyadenosine (CdA) in extracts of peripheral blood mononuclear cells of leukaemic patientsBritish Journal of Haematology, 1994
- Establishment of a karyotypically normal B-chronic lymphocytic leukemia cell line; Evidence of leukemic origin by immunoglobulin gene rearrangementLeukemia Research, 1990
- Mechanism of deoxyadenosine and 2-chlorodeoxyadenosine toxicity to nondividing human lymphocytes.Journal of Clinical Investigation, 1985
- Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assaysJournal of Immunological Methods, 1983
- Deoxycytidine kinase-mediated toxicity of deoxyadenosine analogs toward malignant human lymphoblasts in vitro and toward murine L1210 leukemia in vivo.Proceedings of the National Academy of Sciences, 1980
- The performance of microparticle chemically-bonded anion-exchange resins in the analysis of nucleotidesJournal of Chromatography A, 1975